---
figid: PMC3205681__EDR2012-716425.002
figtitle: Post-translational modifications (PTMs) of transcription factors
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3205681
filename: EDR2012-716425.002.jpg
figlink: /pmc/articles/PMC3205681/figure/fig2/
number: F2
caption: Post-translational modifications (PTMs) of transcription factors. (a) The
  positions of PTM sites in the human FOXO1, SREBP-1c, and NF-κB p65 subunit.The positions
  of PTM sites and the implicated modifying enzymes are shown. (+) and (–) represent
  activation and inhibition of the transcriptional activity of transcription factors,
  respectively. L1-2, nuclear localization sequences; E1-3, nuclear export sequences;
  DBD, DNA-binding domain; TAD, transactivation domain; RHD, Rel homology domain;
  NLS, nuclear localization sequence; TAD, transactivation domain. (b) Regulation
  of FOXO1 nucleocytoplasmic shuttling and transcriptional activity by PTMs in liver.
  (c) Regulation of transcription factor activities by PTMs in pancreatic β cells.
  P, phosphate group; Ac, acetyl group; G, O-linked-N-acetylglucosamine; Ub, ubiquitin;
  S, SUMO; Akt, v-akt murine thymoma viral oncogene homolog 1 (also known as protein
  kinase B [PKB]); SGK, serum/glucocorticoid-regulated kinase; CK1, casein kinase
  1; DYRK1A, dual-specificity tyrosine-phosphorylated and regulated kinase1 A; CDK2,
  cyclin-dependent kinase 2. PI3K, phosphoinositide-3-kinase; PDK, phosphatidylinositol-dependent
  protein kinase; OGT, O-linked N-acetylglucosamine (GlcNAc) transferase; MAPK1/3,
  mitogen-activated protein kinase 1/3; Ubc9, ubiquitin conjugating enzyme 9; p300,
  E1A-binding protein p300; CBP, CREB-binding protein; SIRT1, sirtuin 1; PKA, protein
  kinase A; cAMP, cyclic adenosine monophosphate; SIK, salt-inducible kinase; GSK-3,
  glycogen synthase kinase-3; JNK, c-Jun N-terminal kinase; PCAF, CBP/p300-associated
  factor; MSK1, mitogen/stress-activated protein kinase 1; PKCζ, protein kinase Cζ;
  IKK, I kappa B kinase; CK2, casein kinase 2; TBK1, tank-binding kinase 1; SOCS-1,
  suppressor of cytokine signaling 1; HBP, hexosamine biosynthesis pathway; OGA, O-GlcNAcase;
  PDX1, pancreatic and duodenal homeobox 1; NeuroD, neurogenic differentiation; MafA,
  v-maf (maf musculoaponeurotic fibrosarcoma) oncogene homolog A.
papertitle: Role of Transcription Factor Modifications in the Pathogenesis of Insulin
  Resistance.
reftext: Mi-Young Kim, et al. Exp Diabetes Res. 2012;2012:716425.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5421501
figid_alias: PMC3205681__F2
figtype: Figure
redirect_from: /figures/PMC3205681__F2
ndex: 997c4ec1-df36-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3205681__EDR2012-716425.002.html
  '@type': Dataset
  description: Post-translational modifications (PTMs) of transcription factors. (a)
    The positions of PTM sites in the human FOXO1, SREBP-1c, and NF-κB p65 subunit.The
    positions of PTM sites and the implicated modifying enzymes are shown. (+) and
    (–) represent activation and inhibition of the transcriptional activity of transcription
    factors, respectively. L1-2, nuclear localization sequences; E1-3, nuclear export
    sequences; DBD, DNA-binding domain; TAD, transactivation domain; RHD, Rel homology
    domain; NLS, nuclear localization sequence; TAD, transactivation domain. (b) Regulation
    of FOXO1 nucleocytoplasmic shuttling and transcriptional activity by PTMs in liver.
    (c) Regulation of transcription factor activities by PTMs in pancreatic β cells.
    P, phosphate group; Ac, acetyl group; G, O-linked-N-acetylglucosamine; Ub, ubiquitin;
    S, SUMO; Akt, v-akt murine thymoma viral oncogene homolog 1 (also known as protein
    kinase B [PKB]); SGK, serum/glucocorticoid-regulated kinase; CK1, casein kinase
    1; DYRK1A, dual-specificity tyrosine-phosphorylated and regulated kinase1 A; CDK2,
    cyclin-dependent kinase 2. PI3K, phosphoinositide-3-kinase; PDK, phosphatidylinositol-dependent
    protein kinase; OGT, O-linked N-acetylglucosamine (GlcNAc) transferase; MAPK1/3,
    mitogen-activated protein kinase 1/3; Ubc9, ubiquitin conjugating enzyme 9; p300,
    E1A-binding protein p300; CBP, CREB-binding protein; SIRT1, sirtuin 1; PKA, protein
    kinase A; cAMP, cyclic adenosine monophosphate; SIK, salt-inducible kinase; GSK-3,
    glycogen synthase kinase-3; JNK, c-Jun N-terminal kinase; PCAF, CBP/p300-associated
    factor; MSK1, mitogen/stress-activated protein kinase 1; PKCζ, protein kinase
    Cζ; IKK, I kappa B kinase; CK2, casein kinase 2; TBK1, tank-binding kinase 1;
    SOCS-1, suppressor of cytokine signaling 1; HBP, hexosamine biosynthesis pathway;
    OGA, O-GlcNAcase; PDX1, pancreatic and duodenal homeobox 1; NeuroD, neurogenic
    differentiation; MafA, v-maf (maf musculoaponeurotic fibrosarcoma) oncogene homolog
    A.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - foxo
  - Akt
  - Tpi
  - CkIalpha
  - CBP
  - nej
  - eIF4E1
  - pr
  - sxc
  - MKP-4
  - p38b
  - rl
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Sik2
  - Sik3
  - Rich
  - RyR
  - Dif
  - dl
  - Rel
  - IKKepsilon
  - key
  - IKKbeta
  - Gcn5
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - kri
  - tra
  - byn
  - Traf6
  - Traf4
  - Sara
  - ac
  - Acp26Ab
  - Acp26Aa
  - CG18284
  - Acp36DE
  - SP
  - Acp95EF
  - Acph-1
  - Pdk
  - Pdk1
  - Oga
  - pirk
  - bsk
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - AKT1
  - AKT2
  - AKT3
  - SGK1
  - CHKA
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - OGT
  - EOGT
  - POMGNT1
  - POMGNT2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - SIK1
  - SIK2
  - SIK3
  - RYR1
  - RYR2
  - RYR3
  - NFKB1
  - CHUK
  - KAT2B
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - GEM
  - KIR3DL1
  - TRA
  - THRA
  - TRAC
  - TRAF1
  - TRAF2
  - TRAF3
  - TRAF4
  - TRAF5
  - TRAF6
  - TRAF7
  - SRI
  - ZFYVE9
  - SAR1A
  - ACACA
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - NDUFAB1
  - CPAT1
  - RHD
  - PHGDH
  - SOCS1
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - OGA
  - PODXL
  - NEUROD1
  - FLNA
  - MAFA
  - KLRG1
  - VILL
  - Glucose
  - Ser
  - UDP
  - Cancer
---
